Recent Advances in the Understanding of Sepsis-Induced Alterations in the Neuroendocrine System

被引:16
|
作者
Wahab, Fazal [1 ,2 ]
Atika, Bibi [2 ]
Oliveira-Pelegrin, Gabriela Ravanelli [1 ]
Alves Rocha, Maria Jose [1 ]
机构
[1] Univ Sao Paulo, Dept Morphol Physiol & Basic Pathol, FORP, BR-14040904 Sao Paulo, Brazil
[2] Khyber Med Univ, Inst Basic Med Sci, Dept Physiol, Peshawar, Pakistan
基金
巴西圣保罗研究基金会;
关键词
Cytokines; hormonal therapy; hypothalamus; immune system; neuroendocrine system; neuroendocrinopathy; pituitary; sepsis; PITUITARY-ADRENAL AXIS; THYROTROPIN-RELEASING-HORMONE; INNATE IMMUNE-RESPONSES; NITRIC-OXIDE SYNTHASE; GENE-EXPRESSION; INDUCED SUPPRESSION; VASOPRESSIN SECRETION; MAGNOCELLULAR NEURONS; NONTHYROIDAL ILLNESS; CECAL LIGATION;
D O I
10.2174/1871530313666131211120723
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sepsis is a fatal systemic inflammatory disease. It is caused by an immune system inflammatory response to the entry of microorganisms or their products into the blood circulatory system. The pathophysiological mechanisms of sepsis are still poorly understood. The presence of microorganisms in the systemic circulation causes activation of the immune system, which in turn leads to a robust release of inflammatory cytokines. These inflammatory cytokines result in alterations across all important physiological systems, including the neuroendocrine system. Neuroendocrine responses differ between the acute and the late phase of sepsis. In the acute phase there are robust alterations in the secretion of neuroendocrine hormones in response to body demand. In the late phase, the plasma concentrations of some hormones remain low, despite heavy systemic demand, whereas several others increase despite of diminished needs. In this review, we give a brief overview on sepsis-induced major alterations in neuroendocrine secretions, and summarize current knowledge about mechanisms and targets for their treatment.
引用
收藏
页码:335 / 347
页数:13
相关论文
共 50 条
  • [21] Deeper understanding of mechanisms contributing to sepsis-induced myocardial dysfunction
    Keith R Walley
    Critical Care, 18
  • [22] SEPSIS-INDUCED ALTERATIONS IN PHOSPHOENOLPYRUVATE CARBOXYKINASE EXPRESSION - THE ROLE OF INSULIN AND GLUCAGON
    DEUTSCHMAN, CS
    DEMAIO, A
    BUCHMAN, TG
    CLEMENS, MG
    CIRCULATORY SHOCK, 1993, 40 (04) : 295 - 302
  • [23] Alterations in pulmonary surfactant during the course of sepsis-induced ARDS predisposition
    Stamme, C
    Leuwer, M
    Luhrs, J
    Ensink, M
    Tschorn, H
    Vangerow, B
    Ruckoldt, H
    Schurmann, W
    Bernhard, W
    Piepenbrock, S
    ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY, 1996, 6 (04): : 223 - 232
  • [24] Sepsis-induced cholestasis
    Chand, Nisha
    Sanyal, Arun J.
    HEPATOLOGY, 2007, 45 (01) : 230 - 241
  • [25] Sepsis-induced Cardiomyopathy
    Romero-Bermejo, Francisco J.
    Ruiz-Bailen, Manuel
    Gil-Cebrian, Julian
    Huertos-Ranchal, Maria J.
    CURRENT CARDIOLOGY REVIEWS, 2011, 7 (03) : 163 - 183
  • [26] IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis
    Lang, CH
    Fan, J
    Cooney, R
    Vary, TC
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 270 (03): : E430 - E437
  • [27] Sepsis-induced Cholestasis
    Giovannini, Ivo
    Chiarla, Carlo
    Giuliante, Felice
    Vellone, Maria
    Ardito, Francesco
    Nuzzo, Gennaro
    HEPATOLOGY, 2008, 47 (01) : 361 - 361
  • [28] Sepsis-Induced Immunosuppression
    Torres, Lisa K.
    Pickkers, Peter
    van der Poll, Tom
    ANNUAL REVIEW OF PHYSIOLOGY, 2022, 84 : 157 - 181
  • [29] Recent advances in understanding hard tissue alterations related to trauma
    Ubelaker, Douglas H.
    FORENSIC SCIENCE INTERNATIONAL, 2019, 299 : 235 - 237
  • [30] ENDOTOXIN INHIBITOR PREVENTS SEPSIS-INDUCED ALTERATIONS IN INTESTINAL ION-TRANSPORT
    WHANG, EE
    DUNN, JC
    MAHANTY, HD
    ZINNER, MJ
    MCFADDEN, DW
    ASHLEY, SW
    GASTROENTEROLOGY, 1995, 108 (04) : A1251 - A1251